Floatz logo

Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs

Graft vs Host Disease

Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyCell therapyPhase 2/3Dormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

34 Active assets in the Graft vs Host Disease cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
City of Hope Medical Center
Phase 4BBB
Busulphan
City of Hope Medical Center
Phase 4BBB
Thiotepa
Memorial Sloan Kettering Cancer Center
Phase 4BBB
FILGRASTIM
City of Hope Medical Center
Phase 4BBB
CYCLOSPORIN A
Memorial Sloan Kettering Cancer Center
Phase 3BB

View all 50 →

Same molecule, other indications

Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs is also rated in:

acute lymphoblastic leukemiaDormant
BBB
Indicative ·
74 / 100
View asset →
Acute Myelogenous LeukemiaDormant
BB
Indicative ·
70 / 100
View asset →
Myelodysplastic SyndromesDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →